![]() |
|
|
LA Sebring and RJ Huxtable
A sarcolemma-enriched membrane fraction (SL) was prepared from the hearts of Sprague-Dawley rats and its ability to bind Ca++ was measured by equilibrium dialysis. We found that the effect of taurine on SL Ca++ binding varied with the buffer and with Na+ concentration. In Tris, in the presence of Na+ (140 mM), taurine (10 mM) increased the affinity but decreased the maximal binding of Ca++ (0.5-7 mM). In the absence of Na+, taurine decreased the affinity without altering the maximal binding. These effects on Ca++ binding were absent in bicarbonate or Krebs-Henseleit buffers. However, incubations with A23187, a Ca++ ionophore, and lanthanum, a Ca++ antagonist, indicated that SL membranes incubated in Tris, but not in buffers containing bicarbonate, were sealed vesicles with internal environments low in Ca++. High- affinity binding of Ca++ (10(-6)-10(-4) M) was measured in modified Krebs-Henseleit buffers. Taurine decreased Ca++ binding in a high-Na+ (145 mM), low-K+ (4.7 mM) buffer. Taurine increased Ca++ binding in both 4.7 mM Na+-145 mM K+ and 25 mM Na+-4.7 mM K+ buffers. Taurine also increased Ca++ binding in the presence of ATP. Thus, taurine increased high-affinity Ca++ binding in "intracellular" buffers, but it did not affect low-affinity Ca++ binding in "extracellular" buffers. These results suggest taurine may exert its cardiotonic actions through modulation of the high-affinity Ca++ binding sites on the internal aspect of the SL.
This article has been cited by other articles:
![]() |
F. Li, I. G. Obrosova, O. Abatan, D. Tian, D. Larkin, E. L. Stuenkel, and M. J. Stevens Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E29 - E36. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Han, J. H. Bae, S.-Y. Kim, H.-Y. Lee, B.-C. Jang, I.-K. Lee, C.-H. Cho, J.-G. Lim, S.-I. Suh, T.-K. Kwon, et al. Taurine increases glucose sensitivity of UCP2-overexpressing {beta}-cells by ameliorating mitochondrial metabolism Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E1008 - E1018. [Abstract] [Full Text] [PDF] |
||||